Boost Beauty and Confidence
LANLUMA is a collagen stimulating injectable filler for the face and body that contours, reshapes and activates the production of natural collagen, so patients can wear their new-found confidence.
GET IN TOUCHBoost Beauty and Confidence
LANLUMA is a collagen stimulating injectable filler for the face and body that contours, reshapes and activates the production of natural collagen, so patients can wear their new-found confidence.
GET IN TOUCHLanluma is not the same as HA fillers, because it doesn’t simply fill up areas you would like to perfect with a gel. Instead, clever PLLA particles get to work deep within the skin to activate your body’s own natural collagen response that last more than 2 years. (J Am Acad Dermatol 2010;62:448-62)
REQUEST A DEMOWe provide extensive training for our physicians to create highly trained injectors and work with the very best physicians in the industry. Lanluma’s main ingredient, injectable PLLA stimulates the natural production of the body ‘s own collagen and provide effects that last more than 2 years (J Am Acad Dermatol 2010;62:448-62)
SPEAK WITH OUR VIRTUAL ACCOUNT MANAGERSINDICATION
Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions.
1023 GANA R&D Co., Ltd., 905, 555, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea. CorWeb.03
Please review here the Lanluma Summary of Safety and Clinical Performance (SSCP – Switzerland only)
NOTICE
Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.
Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.
El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.
INDICATION
Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions.
IMPORTANT SAFETY CONSIDERATIONS
Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.
The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Lanluma distributor. Alternatively send the details to Sinclair on: quality@sinclairpharma.com
For a full list of contraindications, warnings and precautions for this product please visit https://www.sinclairpharma.com/eifu for copy of the Product Instructions for Use.